Vedolizumab
SAHoWMU-CR2025-01-130
Approved mab completed
Quick answer
Vedolizumab for Ulcerative Colitis (UC) is a Approved program (mab) at Second Affiliated Hospital of Soochow University with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Second Affiliated Hospital of Soochow University
- Indication
- Ulcerative Colitis (UC)
- Phase
- Approved
- Modality
- mab
- Status
- completed